Severe hematuria in a patient receiving bevacizumab and pembrolizumab for metastatic cervical cancer: a case report.
BMC Nephrol
; 24(1): 51, 2023 03 10.
Article
in En
| MEDLINE
| ID: mdl-36899322
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Uterine Cervical Neoplasms
/
Lung Neoplasms
Type of study:
Etiology_studies
Limits:
Aged
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
BMC Nephrol
Journal subject:
NEFROLOGIA
Year:
2023
Document type:
Article
Affiliation country:
China